Keros Therapeutics, Inc. Profile Avatar - Palmy Investing

Keros Therapeutics, Inc.

Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. T…

Biotechnology
US, Lexington [HQ]
Strategy & Leadership

Officers & BofD Beta

  • Form 3/4/5
  • Proxy DEF-14A

Total Compensation

- No data, only available if we have DEF 14A compensations in place -
Officers
Name & Position Research Last Appearance
- No data available -
Board of Directors (BofD)
Name & Position Research Last Appearance
- No data available -
End of KROS's Analysis
CIK: 1664710 CUSIP: 492327101 ISIN: US4923271013 LEI: - UEI: -
Secondary Listings
KROS has no secondary listings inside our databases.